Get the Stockscreener App
57.20
4.27%
2.34
Pre-market:
57.15
-0.05
-0.09%
Lantheus Holdings Inc stock is traded at $57.20, with a volume of 2.50M.
It is up +4.27% in the last 24 hours and down -30.59% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$54.86
Open:
$54.9
24h Volume:
2.50M
Relative Volume:
1.71
Market Cap:
$3.96B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
9.5175
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-18.95%
1M Performance:
-30.59%
6M Performance:
-35.52%
1Y Performance:
-41.19%
1-Day Range:
$53.69
$57.21
1-Week Range:
$47.25
$73.72
52-Week Range:
$47.25
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
57.20 | 3.59B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook - MSN
Lantheus lowers 2025 revenue and EPS outlook, targets $1.475B–$1.51B revenue as pricing pressures persist - MSN
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2025 Earnings Call Transcript - Insider Monkey
Lantheus Holdings, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - uk.finance.yahoo.com
Lantheus Holdings Inc’s Mixed Earnings Call: Challenges and Strategic Advances - TipRanks
Best Mid Cap Stocks To ResearchAugust 6th - MarketBeat
LNTH: Competition Escalates in PSMA Imaging - Zacks Small Cap Research
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns - Investing.com Australia
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns By Investing.com - Investing.com South Africa
Did Lantheus Holdings, Inc. (LNTH) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Lantheus Holdings: Mizuho Downgrades to Outperform, PT to $70 from $120. - AInvest
Lantheus (LNTH) shares plummet 33.1% to $48.62. - AInvest
Lantheus Holdings 2025 Q2 Earnings Earnings Surge 26.9% Despite Revenue Dip - AInvest
Lantheus Holdings shares rise 1.79% premarket after announcing a $400 million share repurchase program. - AInvest
Lantheus stock price target lowered to $73 at JMP on pricing pressure - Investing.com Australia
Lantheus Holdings (LNTH) Announces US$400 Million Buyback Amid FDA and Earnings Updates - simplywall.st
Lantheus Holdings Reports Q2 2025 Results and Strategic Moves - TipRanks
Lantheus Shares Tumble 28.58% on $700M Trading Surge to 143rd Rank as FDA Progress and Strategic Moves Unfold - AInvest
Lantheus Holdings shares rise 1.18% after-hours after announcing a $400 million share repurchase program. - AInvest
FDA accepts Lantheus’ NDA for new Pylarify formulation - AuntMinnie
Lantheus Holdings: Q2 Earnings Snapshot - Chron
Why Lantheus (LNTH) Stock Is Falling Today - Yahoo Finance
Lantheus Shares Slide As Earnings And Outlook Fall Short - Finimize
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on November 20, 2024. - MarketScreener
Lantheus Holdings, Inc. announces an Equity Buyback for $400 million worth of its shares. - MarketScreener
Lantheus Q2 2025 slides: revenue falls 4.1%, company slashes full-year guidance - Investing.com Canada
Lantheus Holdings: Reassessing The Buy Thesis (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings stock hits 52-week low at $51.75 By Investing.com - Investing.com Australia
Lantheus Holdings stock hits 52-week low at $51.75 - Investing.com
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge - Investing.com India
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge By Investing.com - Investing.com Nigeria
Lantheus Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lantheus announces FDA review for new radioactive imaging agent - MSN
Lantheus Holdings Inc Q2 2025 Earnings: EPS Surges to $1.12, Bea - GuruFocus
Lantheus Holdings Inc earnings missed by $0.10, revenue fell short of estimates - Investing.com
Lantheus Q2 Adjusted Earnings, Revenue Fall; Lowers 2025 Guidance; Shares Drop Pre-Bell - MarketScreener
Lantheus Holdings Plunges 22.21% on Missed Q2 Earnings - AInvest
Lantheus Announces FDA Acceptance of New Drug Application - TipRanks
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% - Yahoo Finance
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Why Lantheus Shares Are Taking a Hit - TipRanks
Lantheus stock slips on Q2 miss amid regulatory win (LNTH) - Seeking Alpha
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation By Investing.com - Investing.com Nigeria
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation - Investing.com India
Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating - MSN
Earnings Flash (LNTH) Lantheus Holdings, Inc. Posts Q2 Adjusted EPS $1.57 per Share, vs. FactSet Est of $1.68 - MarketScreener
Lantheus Q2 rev. $378mln, adj. EPS $1.57, FDA okays new imaging agent, buys Life Molecular Imaging. - AInvest
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update - Stock Titan
Breakthrough: FDA Reviews New PSMA Imaging Formula That Could Help Thousands More Prostate Cancer Patients - Stock Titan
Lantheus Q2 Earnings Preview: Analyst Expectations and Potential Upside - AInvest
Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings - MSN
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):